Jump to main content
電子書籍・電子雑誌Tropical medicine and health
Volume number47
Evaluation...

Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo

Icons representing 記事
The cover of this title could differ from library to library. Link to Help Page

Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo

Persistent ID (NDL)
info:ndljp/pid/11377424
Material type
記事
Author
Gaber El-Saber Batihaほか
Publisher
Springer Nature
Publication date
2019-07-11
Material Format
Digital
Journal name
Tropical medicine and health 47(42)
Publication Page
-
View Details

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある電子書籍・電子雑誌の提供元Webサイトなどから、本文を自由に閲覧できる場合があります。

Detailed bibliographic record

Summary, etc.:

application/pdfBackground: Treatment is the principle way to control and eliminate piroplasmosis. The search for new chemotherapy against Babesia and ...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    Digital
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
記事
Author/Editor
Gaber El-Saber Batiha
Amani Magdy Beshbishy
Dickson Stuart Tayebwa
Publication, Distribution, etc.
Publication Date
2019-07-11
Publication Date (W3CDTF)
2019-07-11
Periodical title
Tropical medicine and health
No. or year of volume/issue
47(42)
Volume
47(42)
ISSN (Periodical Title)
1349-4147
ISSN-L (Periodical Title)
1348-8945
Text Language Code
eng
Persistent ID (NDL)
info:ndljp/pid/11377424
Collection (Materials For Handicapped People:1)
Collection (particular)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
Acquisition Basis
オンライン資料収集制度
Date Accepted (W3CDTF)
2019-10-28T20:45:15+09:00
Date Captured (W3CDTF)
2019-10-28
Format (IMT)
application/pdf
Access Restrictions
国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service
図書館・個人送信対象外
Availability of remote photoduplication service
Periodical Title (Persistent ID (NDL))
info:ndljp/pid/11285294
Data Provider (Database)
国立国会図書館 : 国立国会図書館デジタルコレクション

Digital

Summary, etc.
application/pdf
Background: Treatment is the principle way to control and eliminate piroplasmosis. The search for new chemotherapy against Babesia and Theileria has become increasingly urgent due to parasite resistance to current drugs. Ivermectin (IVM) was the world's first endectocide, capable of killing a wide variety of parasites and vectors, both inside and outside the body. It is currently authorized to treat onchocerciasis, lymphatic filariasis, strongyloidiasis, and scabies. The current study documented the efficacy of IVM on the growth of Babesia and Theileria in vitro and in vivo. Methods: The fluorescence-based assay was used for evaluating the inhibitory effect of IVM on four Babesia species, including B. bovis, B. bigemina, B. divergens, B. caballi, and Theileria equi, the combination with diminazene aceturate (DA), clofazimine (CF), and atovaquone (AQ) on in vitro cultures, and on the multiplication of a B. microti-infected mouse model. The cytotoxicity of compounds was tested on Madin-Darby bovine kidney (MDBK), mouse embryonic fibroblast (NIH/3 T3), and human foreskin fibroblast (HFF) cell lines. Results: The half-maximal inhibitory concentration (IC50) values determined for IVM against B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi were 53.3 ± 4.8, 98.6 ± 5.7, 30.1 ± 2.2, 43.7 ± 3.7, and 90.1 ± 8.1 μM, respectively. Toxicity assays on MDBK, NIH/3 T3, and HFF cell lines showed that IVM affected the viability of cells with a half-maximal effective concentration (EC50) of 138.9 ± 4.9, 283.8 ± 3.6, and 287.5 ± 7.6 μM, respectively. In the in vivo experiment, IVM, when administered intraperitoneally at 4 mg/kg, significantly (p < 0.05) inhibited the growth of B. microti in mice by 63%. Furthermore, combination therapies of IVM-DA, IVM-AQ, and IVM-CF at a half dose reduced the peak parasitemia of B. microti by 83.7%, 76.5%, and 74.4%, respectively. Moreover, this study confirmed the absence of B. microti DNA in groups treated with combination chemotherapy of IVM + DA and IVM + AQ 49 days after infection. Conclusions: These findings suggest that IVM has the potential to be an alternative remedy for treating piroplasmosis. © 2019 The Author(s).
Access Restrictions
インターネット公開
Rights (production)
This is an open access article licensed under the terms of the Creative Commons Attribution (by) License. <http://creativecommons.org/lisenses/by/4.1/>
Is Referenced By
Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria
Phytochemical Characterization and Chemotherapeutic Potential of Cinnamomum verum Extracts on the Multiplication of Protozoan Parasites In Vitro and In Vivo
Therapeutic Effects of Atranorin towards the Proliferation of Babesia and Theileria Parasites
Data Provider (Database)
国立情報学研究所 : CiNii Research
Bibliographic ID (NDL)
11377424
NAID
120006727119